In Pharmaceutical Commerce magazine, Tangent90 CEO Jan van den Burg discusses the value that HCPs place on scientific content and highlights the opportunity that pharma should be taking now.
Veeva recently published an eBook which discusses the best practice approach for supporting emerging pharma to launch and scale content faster. It focuses on how digital communications have allowed field teams to spend more quality time with HCPs. What can pharma’s brand teams do to support the increase needed?
We have been inundated with discussions about big data. Information that can help inform decision making is an output of nearly every phase in life sciences. The industry, with the increased use of digital channels, has been able to collect more data but is this being used to optimise their HCP engagement strategies?
The use of digital communications comes with new challenges when compared to the traditional paper era. Whilst virtual events and online publications and documents are nothing new, the increased reliance on them is, and there is a danger that digital fatigue could set in if the content is not tailored to the user.
The more information you have, the better informed you are. Data offers the ability to tailor and personalise the customer experience. But are we doing enough and what opportunities are there to optimise HCP engagement?
With demand for in-person, fully virtual and hybrid events high and expected to remain so, the hybrid approach needs to ensure it can cater for the different audience requirements, whilst at the same time, continuing to deliver quality information.
Tangent90 Ltd, a leading technology company that enables pharma to overcome the challenges of sharing scientific digital content with healthcare professionals, welcome the appointment of John Robson as Account Director.
A recent article on PharmExec.com by Paul Shawah, Executive Vice President of Commercial Strategy at Veeva Systems, highlighted the opportunity COVID has presented for pharma to accelerate digital transformation.
McKinsey & Company recently undertook a survey of senior executives in commercial roles within global pharma, to understand their thoughts on how the pandemic has influenced and changed the strategic and operational approach to ongoing engagement.
Tangent90 Ltd, a leading technology company developing innovative solutions that enable pharma to overcome the challenges of sharing scientific digital content with healthcare professionals (HCPs), welcome the appointment of Gemma Cholerton as Marketing Director.
Jan van den Burg has left life science industry cloud giant, Veeva Systems to join Tangent90, the Industry’s best kept secret in digital innovation.
The Neu-Isenburg agency can now offer digital distribution of scientific content in the healthcare industry with its future-proof software solution, Trustrack.
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.